In this study, BIRC2 was identified as a direct target of BRD7, which functions as a transcriptional regulatory factor to inhibit carcinogenesis and tumor progression at least partially by negatively regulating the enhancer activation and expression of BIRC2 in NPC. This evidence concerns the gene BRD7 and nasopharyngeal carcinoma.